Chronic Illness Survey Adventure Finishing this Month!

Two years ago, #MEAction embarked on an ambitious project, the Chronic Illness Survey Adventure! The Adventure is a survey to deeply examine the symptoms experienced by people with diseases that are triggered or unmasked by infection, including ME, POTS, hEDS, MCAS, and Long COVID.  At the end of this year, we will close the Adventure with over 1.5 million data points illustrating the connections between these diseases’ symptom presentation, and what makes each disease– and each person living with these conditions– unique.

That’s 1.5M data points for completed surveys only– that is, for individuals who have taken all five survey sections.  In reality, we actually have many, many times that.  That’s just the very best, most complete data.

When we started the Survey our goal was to have 2,000 people complete the survey and currently nearly ~1950 individuals have completed the survey.  We’re aiming for 2,000 or more.  If you’ve taken at least one section of the survey, now is the perfect time to finish up!  Check your email for invites over the next few days and visit the survey landing page, www.meaction.net/epi, to check for updates and receive help if needed.

We’re collecting some very important data with this survey, some of it for the first time!

We’ve been able to survey a diverse group of responders.  This is important because infection-associated chronic illnesses are so under-researched in most populations.  We may be able to learn for the first time if ME is experienced differently by different groups.

Here is some interesting data on who responded to the survey regarding which diagnoses they had from a clinician.

  • 554 people had mast cell activation disorder (MCAS)
  • 2763 said they’d been diagnosed with chronic fatigue syndrome (CFS); 2579 said they’d been diagnosed with ME/CFS; and 1271 said they’d been diagnosed with myalgic encephalomyelitis.
  • ~700 had a diagnosis of Ehlers-Danlos syndrome(s)
  • 1349 had a POTS diagnosis
  • 1400 had a diagnosis of fibromyalgia

If you’ve already taken at least one section of the survey, keep an eye out for your invites this month!  

If you are interested in starting the survey, which is in five parts, you can sign up here: www.meaction.net/epi/quiet.  Then, you can check your email for an invite with a link to begin!

We’re looking forward to doing a deep dive into this data starting in the new year.  Thank you for your participation and all your help along the way!

Sincerely,
Jaime Seltzer
Scientific Director

Facebook
Twitter
WhatsApp
Email

Latest News

Blue square image with starbursts in the corners. the words, submit long covid drug recommendations to recover -tlc! are in the middle of the image, surrounded by thin white lines. the meaction logo is at the top of the image.

Submit Long COVID Drug Recommendations to RECOVER-TLC!

Last month, RECOVER TLC met at NIH headquarters in Bethesda. The goal was to initiate a drug development strategy for Long COVID clinical trials. Now, RECOVER TLC has opened the RECOVER-TLC Intervention Information Request Form, where you can make suggestions about which drugs and other interventions to trial!  Anyone can submit a therapeutic for consideration

Read More »
A classroom of people watching a panel discussion.

The RECOVER-Treating Long COVID (RECOVER TLC) The Path Forward

The RECOVER-Treating Long COVID (RECOVER TLC) Kick-off Meeting was Sept 23-25 in person and over Zoom. I had the privilege of attending over Zoom and Jaime Seltzer, #MEAction’s Scientific Director, represented the needs of the ME community in person and as an invited member of a panel on clinical trial design. There were many speakers

Read More »
Scroll to Top